These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Zubieta JK; Gorelick DA; Stauffer R; Ravert HT; Dannals RF; Frost JJ Nat Med; 1996 Nov; 2(11):1225-9. PubMed ID: 8898749 [TBL] [Abstract][Full Text] [Related]
50. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Liberzon I; Zubieta JK; Fig LM; Phan KL; Koeppe RA; Taylor SF Proc Natl Acad Sci U S A; 2002 May; 99(10):7084-9. PubMed ID: 12011464 [TBL] [Abstract][Full Text] [Related]
51. 18F-labeled sufentanil for PET-imaging of mu-opioid receptors. Henriksen G; Platzer S; Hauser A; Willoch F; Berthele A; Schwaiger M; Wester HJ Bioorg Med Chem Lett; 2005 Apr; 15(7):1773-7. PubMed ID: 15780604 [TBL] [Abstract][Full Text] [Related]
52. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects. Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962 [TBL] [Abstract][Full Text] [Related]
53. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers. Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535 [TBL] [Abstract][Full Text] [Related]
55. An updated synthesis of [ Blecha JE; Henderson BD; Hockley BG; VanBrocklin HF; Zubieta JK; DaSilva AF; Kilbourn MR; Koeppe RA; Scott PJH; Shao X J Labelled Comp Radiopharm; 2017 Jun; 60(8):375-380. PubMed ID: 28419528 [TBL] [Abstract][Full Text] [Related]
56. An updated synthesis of N Kaur T; Brooks AF; Hockley BG; Torres J; Henderson BD; Scott PJH; Shao X J Labelled Comp Radiopharm; 2021 Apr; 64(4):187-193. PubMed ID: 33274468 [TBL] [Abstract][Full Text] [Related]
57. Positron emission tomography as a research tool in the investigation of psychiatric and psychological disorders. Jones AK; Friston K; Dolan R Baillieres Clin Endocrinol Metab; 1991 Mar; 5(1):187-203. PubMed ID: 1645517 [TBL] [Abstract][Full Text] [Related]
58. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino ML; Dannals RF; Frost JJ Psychopharmacology (Berl); 2008 Nov; 200(4):475-86. PubMed ID: 18762918 [TBL] [Abstract][Full Text] [Related]
59. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
60. 6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans. Wester HJ; Willoch F; Tölle TR; Munz F; Herz M; Oye I; Schadrack J; Schwaiger M; Bartenstein P J Nucl Med; 2000 Jul; 41(7):1279-86. PubMed ID: 10914922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]